Acknowledgment

Viral Characteristics of Influenza

Authors: Jonathan P. Moorman MD

Abstract

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. World Health Organization. A revision of the system of nomenclature for influenza viruses: A WHO memorandum. Bull World Health Organ 1980; 58: 585–591.
 
2. Lamb RA, Krug RM. Orthomyxoviridae: The viruses and their replication, in Knipe DM, Howley PM, Griffin DE, et al (eds): Fields’ Virology. Philadelphia, Lippincott Williams & Wilkins, 2001, vol 1, ed 4, pp 1487–1532.
 
3. Murti KG, Webster RG. Distribution of hemagglutinin and neuraminidase on influenza virions as revealed by immunoelectron microscopy. Virology 1986; 149: 36–43.
 
4. Compans RW, Content J, Duesberg PH. Structure of the ribonucleoprotein of influenza virus. J Virol 1972; 10: 795–800.
 
5. White J, Matlin K, Helenius A. Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses. J Cell Biol 1981; 89: 674–679.
 
6. Krug RM, Alonso-Caplen FV, Julkunen I, et al. Expression and replication of the influenza virus genome, in Krug RM (ed): The Influenza Viruses. New York, Plenum, 1989, pp 89–152.
 
7. Enami M, Sharma G, Benham C, et al. An influenza virus containing nine different RNA segments. Virology 1991; 185: 291–298.
 
8. Nobusawa E, Aoyama T, Kato H, et al. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 1991; 182: 475–485.
 
9. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997; 387: 569–572.
 
10. Palese P, Tobita K, Ueda M, et al. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 1974; 61: 397–410.
 
11. Perrotta DM, Decker M, Glezen WP. Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza. Am J Epidemiol 1985; 122: 468–476.
 
12. Neuzil KM, Mellen BG, Wright PF, et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000; 342: 225–231.
 
13. Nichol KL, Margolis KL, Wuorenma J, et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778–784.
 
14. Neuzil KM, Reed GW, Mitchel EF Jr, et al. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA 1999; 281: 901–907.
 
15. Jordan WS. The mechanism of spread of Asian influenza. Am Rev Respir Dis 1961; 83( Suppl): 29–40.
 
16. Six HR, Webster RG, Kendal AP, et al. Antigenic analysis of H1N1 viruses isolated in the Houston metropolitan area during four successive seasons. Infect Immun 1983; 42: 453–458.
 
17. Paniker CK. Serological relationships between the neuraminidases in influenza viruses. J Gen Virol 1968; 2: 385–394.
 
18. Wright PF, Webster RG. Orthomyxoviruses, in Knipe DM, Howley PM, Griffin DE, et al (eds): Fields’ Virology. Philadelphia, Lippincott Williams & Wilkins, 2001, vol 1, ed 4, pp 1533–1579.
 
19. Webster RG, Bean WJ, Gorman OT, et al. Evolution and ecology of influenza A viruses. Microbiol Rev 1992; 56: 152–179.
 
20. Kawaoka Y, Krauss S, Webster RG. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol 1989; 63: 4603–4608.
 
21. Rota PA, Rocha EP, Harmon MW, et al. Laboratory characterization of a swine influenza virus isolated from a fatal case of human influenza. J Clin Microbiol 1989; 27: 1413–1416.
 
22. de Jong JC, Claas EC, Osterhaus AD, et al. A pandemic warning? Nature 1997; 389: 554(letter).
 
23. Wright PF, Thompson J, Karzon DT. Differing virulence of H1N1 and H3N2 influenza strains. Am J Epidemiol 1980; 112: 814–819.
 
24. Ravenholt RT, Foege WH. 1918 influenza, encephalitis lethargica, parkinsonism. Lancet 1982; 2: 860–864.
 
25. Kim HW, Brandt CD, Arrobio JO, et al. Influenza A and B virus infection in infants and young children during the years 1957–1976. Am J Epidemiol 1979; 109: 464–479.
 
26. Schaffer FL, Soergel ME, Straube DC. Survival of airborne influenza virus: Effects of propagating host, relative humidity, and composition of spray fluids. Arch Virol 1976; 51: 263–273.
 
27. Monto AS, Kioumehr F. The Tecumseh Study of Respiratory Illness: Part IX—Occurrence of influenza in the community, 1966–1971. Am J Epidemiol 1975; 102: 553–563.
 
28. Murphy BR, Clements ML. The systemic and mucosal immune response of humans to influenza A virus. Curr Top Microbiol Immunol 1989; 146: 107–116.
 
29. Hayden FG, Fritz R, Lobo MC, et al. Local and systemic cytokine responses during experimental human influenza A virus infection: Relation to symptom formation and host defense. J Clin Invest 1998; 101: 643–649.
 
30. Hers JF. Disturbances of the ciliated epithelium due to influenza virus. Am Rev Respir Dis 1966; 93( Suppl): 162–177.
 
31. Hinshaw VS, Olsen CW, Dybdahl-Sissoko N, et al. Apoptosis: A mechanism of cell killing by influenza A and B viruses. J Virol 1994; 68: 3667–3673.
 
32. Mulder J, Hers JF. Influenza. Groningen, The Netherlands, Wolters-Noordhoff, 1979.
 
33. Puck JM, Glezen WP, Frank AL, et al. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis 1980; 142: 844–849.
 
34. Murphy BR, Kasel JA, Chanock RM. Association of serum anti-neuraminidase antibody with resistance to influenza in man. N Engl J Med 1972; 286: 1329–1332.
 
35. Couch RB, Kasel JA. Immunity to influenza in man. Annu Rev Microbiol 1983; 37: 529–549.
 
36. Wright PF, Murphy BR, Kervina M, et al. Secretory immunological response after intranasal inactivated influenza A virus vaccinations: Evidence for immunoglobulin A memory. Infect Immun 1983; 40: 1092–1095.
 
37. Boyce TG, Gruber WC, Coleman-Dockery SD, et al. Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children. Vaccine 1999; 18: 82–88.
 
38. Scherle PA, Palladino G, Gerhard W. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J Immunol 1992; 148: 212–217.
 
39. Eichelberger M, Allan W, Zijlstra M, et al. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J Exp Med 1991; 174: 875–880.
 
40. Lawson CM, Bennink JR, Restifo NP, et al. Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge. J Virol 1994; 68: 3505–3511.